Search

everythinglearnresearchcommunity

for

Search:↓

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Targeting Vδ1+T-cells may help treat alopecia areata.

A new mutation in the Hr gene causes hair loss in mice, similar to a human hair disorder.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

ILC1-like cells can independently cause alopecia areata.

Nonhuman primates are valuable in research but their natural health variations can complicate study results.

Topical immunotherapy is the best treatment for severe alopecia areata.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Thyroid issues can cause alopecia areata.

Sheep-derived factors improve human hair cell clustering, which may help hair growth.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.